Journal Information
Most often read
11888
Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024J.M. Remes-Troche, E. Coss-Adame, M. Schmulson, K.R. García-Zermeño, M. Amieva-Balmori, R. Carmona-Sánchez, O. Gómez-Escudero, P.C. Gómez-Castaños, ... A.S. Villar-Chávez
Rev Gastroenterol Mex. 2025;90:77-110
11888
Full text access
547
The role of conservative treatment in esophageal perforation caused by the ingestion of a blister pack: A case report and literature reviewJ.P. Pérez-Macías, M.E. Ramírez-Solís, A.Y. Ortega-Caballero, A.I. Hernández-Guerrero, E.F. Marquez-Bornio
Rev Gastroenterol Mex. 2025;90:148-51
547
Full text access
378
Good clinical practice recommendations for proton pump inhibitor prescription and deprescription. A review by experts from the AMGL.R. Valdovinos-García, A.S. Villar-Chávez, F.M Huerta-Iga, M. Amieva-Balmori, J.S. Arenas-Martínez, R. Bernal-Reyes, E. Coss-Adame, O. Gómez-Escudero, ... M.R. Zavala-Solares
Rev Gastroenterol Mex. 2025;90:111-30
378
Full text access
366
Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative studyC. von Muhlenbrock, G. Landskron, A.M. Madrid
Rev Gastroenterol Mex. 2025;90:54-62
366
Full text access
191
Elevated fecal calprotectin: Does capsule endoscopy have a role in the diagnostic algorithm?S. Vibhishanan, P. Oka, S. Zammit, R. Sidhu
Rev Gastroenterol Mex. 2025;90:29-35
191
Full text access
173
Prevalence of extraintestinal manifestations and other associated conditions in a cohort of patients with inflammatory bowel disease at an advanced specialty center in Bogotá, ColombiaJ. Andrade-Restrepo, D. Rubio-Cruz, J.G. Maigual-Quintas, S.G. Sicard-Gómez, E.J. Cuello-Navarro, L.C. Álvarez-Larrota, R. García-Duperly, E.E. Londoño-Schimmer, ... R.P. López-Panqueva
Rev Gastroenterol Mex. 2025;90:44-53
173
Full text access
166
Endoluminal vacuum therapy for the management of acute mediastinitis following esophagogastrectomy: Case report of a patient with esophageal adenocarcinomaG.K. Casadiego, C. Rojas, S. Prado, E. de la Fuente
Rev Gastroenterol Mex. 2025;90:143-6
166
Full text access
151
Splenic tear due to ERCP: A case report and literature reviewG. López-Arce, D. Zamora-Valdés, E. Murcio-Pérez, M.A. Reyes-Caldelas, F.I. Téllez-Ávila
Rev Gastroenterol Mex. 2025;90:146-7
151
Full text access
150
Tradition and advancement: 90 years of excellence of the Asociación Mexicana de GastroenterologíaJ.M. Remes-Troche
Rev Gastroenterol Mex. 2025;90:1-3
150
Full text access
149
Response to Porres-Aguilar et al., on “Periprocedural and perioperative anticoagulation management strategies in liver cirrhosis”J.A. Velarde-Ruiz Velasco, F. Higuera-de-la-Tijera
Rev Gastroenterol Mex. 2025;90:162-4
149
Full text access
146
Eosinophilic esophagitis: Current state and perspectives in Latin AmericaD. García-Compeán
Rev Gastroenterol Mex. 2025;90:4-7
146
Full text access
146
Eosinophilic esophagitis: Current concepts of pathophysiology, diagnosis, and treatmentD. García-Compeán, A.R. Jiménez-Rodríguez, C.E. González-Martínez
Rev Gastroenterol Mex. 2025;90:63-76
146
Full text access
143
Characterization of the epidemiologic, pathologic, radiologic, and management profile of patients with gastrointestinal stromal tumors (GISTs): A 5-year Chilean experienceG. Schiappacasse, R. Cocio, J. Cristi, J. Torres, F. Aliaga, M. Vial, J. Hepp, A. Castiblanco
Rev Gastroenterol Mex. 2025;90:15-21
143
Full text access
140
Noncardiac chest pain beyond the esophagus: Hiatal hernia type III (mixed)C.A. Bautista-Mondragón, J.E. Aquino-Matus, M. Figueroa-Palafox, C. Culebro-García, L.R. Valdovinos-García
Rev Gastroenterol Mex. 2025;90:137-8
140
Full text access
138
Transitioning from NAFLD to MAFLD to MASLD in the Mexican populationB.A. Priego-Parra, R. Bernal-Reyes, M.E. Icaza-Chávez, S.E. Martínez-Vázquez, J.M. Remes-Troche
Rev Gastroenterol Mex. 2025;90:153-6
138
Full text access
135
Comparative analysis of patients transplanted due to hepatocellular carcinoma. Are there survival differences between those who meet the Milan criteria and those who exceed them?M.H. Mohamed-Chairi, A.B. Vico-Arias, N. Zambudio-Carroll, M.T. Villegas-Herrera, J.M. Villar-del-Moral
Rev Gastroenterol Mex. 2025;90:36-43
135
Full text access
134
An App model that utilizes a logistic regression algorithm for predicting choledocholithiasis: A prospective clinical trialF. García-Villarreal, L.M. Torres-Treviño, C. Herrera-Figueroa, J.O. Jáquez-Quintana, A.A. Garza-Galindo, C.A. Cortez-Hernández, D. García-Compeán, R.A. Jiménez-Castillo, ... J.A. González-González
Rev Gastroenterol Mex. 2025;90:22-8
134
Full text access
133
Clinical description of adults with eosinophilic esophagitis treated at a Chilean university centerC. von Muhlenbrock, P. Núñez, R. Quera, J. Venegas, N. Pacheco, K. Herrera, F. Castro
Rev Gastroenterol Mex. 2025;90:8-14
133
Full text access
132
Factor XI/XIa inhibitors for splanchnic vein thrombosis associated with liver cirrhosis: Is there any potential role?M. Porres-Aguilar, W. Ageno, M. Uribe
Rev Gastroenterol Mex. 2025;90:165-6
132
Full text access
125
Gastrointestinal bleeding in an adult patient with Turner syndrome secondary to vascular malformationsF.P. Carvajal-González, P.Y. Gil-Galleguillos, L.C. Gil-La Rota, P.A. Muñoz-Dimitrov, P.F. Toledo-Arancibia
Rev Gastroenterol Mex. 2025;90:139-41
125
Full text access